Histology, circa 1885

An histology slide of US President Ulysses Grant's squamous cell carcinoma from 1885. Credit: Otis Historical Archives, National Museum of Health and Medicine, AFIP, Photo: © Jason Varney | Varneyphoto.com" />An histology slide of US President Ulysses Grant's squamous cell carcinoma from 1885. Credit: Otis Historical Archives, National Museum of Health and Medicine, AFIP, Photo: © Jason Varney | Varneyphoto.com In 1885, pathologist George Elliott was looking through his micr

Written byAlan Hawk
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In 1885, pathologist George Elliott was looking through his microscope at the histological preparation of a tumor pictured here. He noted that "the structure is largely composed of epithelial tissue which in places appears in the form of distinct lobules or "cell nests." In spots the cells show a tendency to group and form concentric globes, which indicates that the cells have been rapidly forming." Based on his findings, Elliott diagnosed the tumor as "epithelioma of a squamous cell variety."

By the time the Armed Forces Institute of Pathology's Dennis Heffner examined the slide in 2000, much had changed: improved histological preparation, better microscope optics, DNA testing, and a more sophisticated understanding of cancer. Heffner observed "some remaining hematoxlin chromasia, reveals an abnormal cellular proliferation. There is a suggestion of an interconnected broad trabecular pattern and whorling of elongated cells." Heffner noted that Elliott had emphasized the lobular cell nest ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies